AptaTargets company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

aptatargets.com

Founded Year

2015

Stage

Series A | Alive

Total Raised

$8.92M

Last Raised

$5.88M | 2 yrs ago

About AptaTargets

AptaTargets is a biopharmaceutical company focused on developing therapeutic applications based on aptamer technology. AptaTarget's drug candidates come from R&D activities in collaboration with research centers of reference. The company specializes in aptamers, DNA, or RNA molecules that can recognize and bond with specific therapeutic targets and are an alternative to antibodies. The first product being developed with these molecules is ApTOLL, an immunomodulatory molecule that could help reduce cerebral inflammation caused by stroke or myocardial infarction, autoimmune diseases, and cancer.

AptaTargets Headquarter Location

Avda. Cardenal Herrera Oria, 298

Madrid, 28035,

Spain

+34 91 007 56 22

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing AptaTargets

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AptaTargets is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

AptaTargets Patents

AptaTargets has filed 3 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/14/2018

10/20/2020

Immune system, Clusters of differentiation, Monoclonal antibodies, Immunology, Autoimmune diseases

Grant

Application Date

12/14/2018

Grant Date

10/20/2020

Title

Related Topics

Immune system, Clusters of differentiation, Monoclonal antibodies, Immunology, Autoimmune diseases

Status

Grant

Latest AptaTargets News

06:00 ET Aptamers Market to Record 26.68% Y-O-Y Growth Rate in 2022|Evolving Opportunities with Aptagen LLC, Aptamer Group Ltd. ...

Dec 21, 2021

Share this article Share this article NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Technavio's latest research report on the Aptamers Market offers a comprehensive analysis of new product launches, the latest trends,  drivers, and challenges . 49% of the growth will originate from North America for the aptamers market. The US and Canada are the key markets for aptamers in North America. However, the market growth rate in this region will be slower than the growth of the market in Asia and Europe. The presence of a well-established healthcare system and high investments in healthcare research and testing will facilitate the aptamers market growth in North America over the forecast period. Attractive Opportunities in Aptamers Market by Application and Geography - Forecast and Analysis 2022-2026 The aptamers market size is expected to increase by USD 1.31 billion, at a CAGR of 27.70% from 2021 to 2026. Aptamers Market is set to record 26.68% of Y-O-Y growth rate in 2022, as per the latest report by Technavio. Market Dynamics Factors such as the increasing incidence of cancer boosting the demand for novel diagnostics, the rising number of clinical trials to develop aptamer-based therapeutics, and the rising awareness of the advantages of aptamers over antibodies will drive the growth of the Aptamers Market. However, inherent challenges associated with oligonucleotide therapies might hamper the market growth. The holistic analysis of the drivers & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge. The aptamers market analysis report also provides detailed information on other upcoming trends that will have a far-reaching effect on the market growth. Company Profiles The aptamers market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The aptamers market report provides complete insights on key vendors including Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc. Few Companies with key offerings Aptagen LLC - The company offers aptamers for biomarker discovery, cell-tissue targeting and imaging, drug discovery, and delivery. Aptamer Group Ltd. - The company offers Optimer binders for their rapid development, batch-to-batch consistency and cost-effective manufacturability, a small molecular size, robust performance, and the ability to bind specifically to a broader target range than other affinity molecules. Aptamer Sciences Inc - The company offers high-quality aptamer discovery, aptamer optimization, and the development of state-of-the-art aptamer therapeutics and diagnostics. APTATARGETS SL - The company offers ApTOLL for aptamer targeting to trigger the immune response at the first steps of the inflammatory pathway. Base Pair Biotechnologies Inc. - The company offers aptamers to target small molecules, pursue toxic and non-immunogenic targets, and penetrate tissues and cells. Competitive Analysis The competitive scenario provided in the aptamers market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc. Market Segmentation By Geography, the market is classified as North America, Europe, Asia, and ROW. Related Reports - Affinity Chromatography Reagents Market -The affinity chromatography reagents market share is expected to increase by USD 435.21 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 9.79%. Download a free sample now! Immunohematology Market -The immunohematology market share is expected to increase by USD 907.43 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 7.75%. Download a free sample now! Aptamers Market Scope Companies profiled Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for forecast period, Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact:

  • When was AptaTargets founded?

    AptaTargets was founded in 2015.

  • Where is AptaTargets's headquarters?

    AptaTargets's headquarters is located at Avda. Cardenal Herrera Oria, 298, Madrid.

  • What is AptaTargets's latest funding round?

    AptaTargets's latest funding round is Series A.

  • How much did AptaTargets raise?

    AptaTargets raised a total of $8.92M.

  • Who are the investors of AptaTargets?

    Investors of AptaTargets include Inveready, Centro para el Desarrollo Tecnologico Industrial, EIT Health, European Institute of Innovation and Technology and Caixa Capital Risc.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.